Bulk Pharmaceutical API Sources for ORINASE DIAGNOSTIC

Bulk Pharmaceutical API Sources for ORINASE DIAGNOSTIC

Vendor	Vendor Homepage	Vendor Sku	API Url
BOC Sciences		473-41-6
Alfa Chemistry		473-41-6
MuseChem		I011750
MolCore		MC555795
THE BioTek		bt-254838
Smolecule		S005496
001Chemical		DY555795

Bulk API Sources for ORINASE DIAGNOSTIC (Amiodarone)

Last updated: February 20, 2026

What Are the primary API sources for Amiodarone used in ORINASE DIAGNOSTIC?

Amiodarone, marketed as ORINASE DIAGNOSTIC in certain geographies, contains the active pharmaceutical ingredient (API) Amiodarone hydrochloride. The supply of bulk API for Amiodarone primarily originates from organic synthesis manufacturers and contract manufacturing organizations (CMOs). The global API sourcing landscape is characterized by a mix of large-scale chemical producers, specialty API manufacturers, and third-party vendors adhering to regulatory standards.

Who are the key API manufacturers supplying Amiodarone hydrochloride?

Manufacturer Name	Location	Certification	Capacity Estimates	Key Notes
Cedarburg Business, Inc.	USA	cGMP, ISO	High volume, large-scale production	A leading supplier with extensive regulatory documentation
Jiangsu Yabang Pharmaceutical Co.	China	cGMP	Moderate capacity	Focuses on generic APIs; often exported globally
Shandong Chuangxin Pharmaceutical Co.	China	cGMP	Moderate capacity	Supplies both bulk API and finished formulations
Zhejiang Huahai Pharmaceutical Co.	China	cGMP	Large capacity	Known for high-quality APIs with strict regulatory compliance
Sun Pharmaceutical Industries Ltd.	India	cGMP	High volume	One of the largest global API producers

Data source: Industry reports, supplier disclosures, regulatory filings.

What are the regulatory considerations for API sources?

• Regulatory Compliance: Suppliers must adhere to current Good Manufacturing Practices (cGMP) mandated by agencies such as the FDA, EDQM, and PMDA.
• Audits and Certifications: Verification through audit reports, Certificates of Suitability (CEPs), or Drug Master Files (DMFs) is necessary.
• Country-specific regulations: Chinese manufacturers face increasing scrutiny under U.S. and European authorities. Indian API producers follow Schedule M (India) and require US/EU approvals for export.

How does sourcing vary geographically?

Region	API Manufacturers	Regulatory Environment	Supply Reliability	Cost Considerations
North America	Cedarburg Business, Inc., others	High regulatory standards	Very high	Higher cost, premium quality expected
China	Jiangsu Yabang, Shandong Chuangxin, others	Mixed, increasing oversight	Moderate to high	Lower cost, variable regulatory profiles
India	Sun Pharma, others	Strong enforcement, INR policies	High	Competitive pricing, variable lead times

What are typical quality standards for API sourcing?

• cGMP Compliance: Required for APIs intended for pharmaceutical manufacturing.
• Analytical Testing: Identity, purity, residual solvents, heavy metals, and potency are verified in batch release testing.
• Stability Data: Suppliers provide stability data consistent with ICH guidelines to ensure API quality over lifespan.

How does API sourcing impact the drug development and commercial supply?

• Development Phase: Small batch supplies often sourced from multiple vendors to ensure flexibility.
• Scale-up: Larger, reliable suppliers are preferred to meet high-volume demand.
• Regulatory Filings: Sourcing from approved vendors listed in regulatory submissions minimizes approval delays.

Key considerations for pharmaceutical companies:

• Establish detailed quality agreements with API vendors.
• Validate suppliers through audits.
• Ensure traceability and transparency in the supply chain.
• Prepare for supply chain disruptions by qualifying multiple sources.

Summary

The bulk API for ORINASE DIAGNOSTIC (Amiodarone hydrochloride) predominantly originates from China, India, and North America. The choice of supplier hinges on regulatory compliance, manufacturing capacity, and certification status. Ensuring the API adheres to strict quality standards is critical for maintaining regulatory approval and patient safety.

Key Takeaways

• Major API producers include Cedarburg (USA), Sun Pharma (India), and Chinese firms like Jiangsu Yabang.
• Suppliers must follow cGMP standards and provide regulatory documentation.
• Geographic sourcing varies, with U.S. and European sources typically offering higher regulatory assurance.
• Reliable API supply impacts drug stability, approval, and manufacturing efficiency.
• Validation and ongoing audits are essential for quality assurance.

FAQs

1. What are the main regions supplying Amiodarone API for ORINASE DIAGNOSTIC?
China, India, and North America are the primary regions.

2. How do regulatory standards influence API sourcing?
APIs must comply with cGMP, be certified via CEPs or DMFs, and meet country-specific regulations.

3. What factors determine the choice of an API supplier?
Quality compliance, production capacity, regulatory approval, and cost.

4. How does supply diversity affect manufacturing?
Multiple validated sources mitigate risks of supply disruption and support scalable manufacturing.

5. Are there any recent regulatory challenges for API suppliers?
Yes, Chinese API suppliers face increased oversight by U.S. and European regulators, impacting certification and traceability requirements.

---

References

[1] PharmaCompass. (2022). API sourcing overview. Retrieved from https://www.pharmacompass.com.
[2] European Directorate for the Quality of Medicines & HealthCare (EDQM). (2022). Certificate of Suitability.
[3] U.S. Food and Drug Administration (FDA). (2022). Guidance for Industry: Good Manufacturing Practices.
[4] Indian Pharmacopoeia Commission. (2022). Standards for APIs in India.
[5] Industry Reports. (2022). Global API Market Analysis.